Skip to main content
. 2023 Mar 31;10:1103303. doi: 10.3389/fnut.2023.1103303

Figure 2.

Figure 2

Scatterplot of the genetic causal effect sbetween BCAAs level the risk of AD. (A) Total BCAAs on AD, (B) valine on AD, (C) leucine on AD, (D) isoleucine on AD, (E) AD on total BCAAs, (F) AD on valine, (G) AD on leucine, (H) AD on isoleucine. BCAAs, branched-chain amino acids; AD, Alzheimer's disease.